Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL933103

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of chymotrypsin-like activity of human 20S proteasome in Molt4 cells
12
Total Activities
12
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Cell Type MOLT-4
Confidence 0 — Uncurated / Unknown
Curated By Autocuration

Target

Unchecked (CHEMBL612545)
Type UNCHECKED

Publication

Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.
Dorsey BD, Iqbal M, Chatterjee S, Menta E, Bernardini R, Bernareggi A, Cassarà PG, D'Arasmo G, Ferretti E, De Munari S, Oliva A, Pezzoni G, Allievi C, Strepponi I, Ruggeri B, Ator MA, Williams M, Mallamo JP.
J Med Chem (2008) 51 : 1068 -1072
PubMed 18247547 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
EC50 12 7.30 7.87

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL270515 DELANZOMIB 2.0 1 7.87
CHEMBL272880 1 7.80
CHEMBL270727 1 7.77
CHEMBL410111 1 7.73
CHEMBL325041 BORTEZOMIB 3.0 1 7.68
CHEMBL269875 1 7.68
CHEMBL407947 1 7.68
CHEMBL259675 1 7.57
CHEMBL270762 1 7.57
CHEMBL270936 1 7.50
CHEMBL272906 1 5.87
CHEMBL259677 1 4.89

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL270515 DELANZOMIB EC50 = 13.5 nM 7.87
CHEMBL272880 EC50 = 16.0 nM 7.80
CHEMBL270727 EC50 = 16.9 nM 7.77
CHEMBL410111 EC50 = 18.6 nM 7.73
CHEMBL325041 BORTEZOMIB EC50 = 21.0 nM 7.68
CHEMBL269875 EC50 = 21.0 nM 7.68
CHEMBL407947 EC50 = 21.0 nM 7.68
CHEMBL259675 EC50 = 27.0 nM 7.57
CHEMBL270762 EC50 = 27.0 nM 7.57
CHEMBL270936 EC50 = 32.0 nM 7.50
CHEMBL272906 EC50 = 1353.0 nM 5.87
CHEMBL259677 EC50 = 13000.0 nM 4.89